Improvement of histopathological classification of adrenal gland tumors by genetic differentiation

World Journal of Urology

Volumn 28, Issue 3, 2010, Pages 329-334

  Gruschwitz, Torsten ^a   Breza, Jan ^b   Wunderlich, Heiko ^a   Junker, Kerstin ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b Physics and Informatics   (Slovakia)

Author keywords

Adrenal tumor; Fine needle biopsy; Genetic evaluation; Tumor type differentiation

Indexed keywords

DNA; TUMOR MARKER;

ADENOMA; ADRENAL CORTEX TUMOR; ADRENALECTOMY; ADULT; AGED; ARTICLE; CARCINOMA; CHROMOSOME ABERRATION; CHROMOSOME MAP; CLASSIFICATION; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METHODOLOGY; MIDDLE AGED; NEEDLE BIOPSY; NONPARAMETRIC TEST; PATHOLOGY; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADENOMA; ADRENAL CORTEX NEOPLASMS; ADRENALECTOMY; ADULT; AGED; BIOPSY, FINE-NEEDLE; CARCINOMA; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; COHORT STUDIES; DNA, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 77952876419     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-010-0541-7     Document Type: Article

References (23)

1. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B (1995) Incidentally discovered adrenal masses. Endocrine rev 16: 460-484.
2. Barzon L, Sonino N, Fallo F, Palù G, Boscaro M (2003) 315 Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 149(4): 273-285.
3. Third National Cancer Survey: Incidence Data, National Cancer Institute Monograph (1975) United States Department of Health, Education and Welfare, Public Health Service, National Institute of Health, National Cancer Institute.
4. Ng L, Libertino JM (2003) Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol 169(1): 5-11.
5. Blake MA, Holakere NS, Boland GW (2008) Imaging techniques for adrenal lesion characterization. Radiol Clin North Am 46(1): 65-78.
6. Cerfolio RJ, Vaughan ED Jr, Brennan TG Jr, Hirvela ER (1993) Accuracy of computed tomography in predicting adrenal tumor size. Surg Gynecol Obstet 176(4): 307-309.
7. Weiss LM (1984) Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 8(3): 163-169.
8. Weiss LM, Medeiros LJ, Vickery AL Jr (1989) Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 13(3): 202-206.
9. Hough AJ, Hollifield JW, Page DL, Hartmann WH (1979) Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphologic data. Am J Clin Pathol 72(3): 390-399.
10. van Slooten H, Schaberg A, Smeenk D, Moolenaar AJ (1985) Morphologic characteristics of benign and malignant adrenocortical tumors. Cancer 55(4): 766-773.
11. Saeger W (2000) Histopathological classification of adrenal tumours. Eur J Clin Invest 30(Suppl. 3): 58-62.
12. Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR (2004) The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 25(2): 309-340.
13. Stojadinovic A, Ghossein RA, Hoos A et al (2002) Adrenocortical carcinoma: clinical, morphologic, and molecular characterization. J Clin Oncol 20(4): 941-950.
14. NIH (2002) NIH state-of-the-science statement on management of the clinically inapparent adrenal mass ("incidentaloma"). NIH Consens State Sci Statements 19(2): 1-25.
15. Lumachi F, Borsato S, Tregnaghi A et al (2003) CT-scan, MRI and image-guided FNA cytology of incidental adrenal masses. Eur J Surg Oncol 29(8): 689-692.
16. Telenius H, Carter NP, Bebb CE, Nordenskjold M, Ponder BA, Tunnacliffe A (1992) Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics 13(3): 718-725.
17. Dackiw AP, Lee JE, Gagel RF, Evans DB (2001) Adrenal cortical carcinoma. World J Surg 25(7): 914-926.
18. Zhao J, Speel EJ, Muletta-Feurer S et al (1999) Analysis of genomic alterations in sporadic adrenocortical lesions. Gain of chromosome 17 is an early event in adrenocortical tumorigenesis. Am J Pathol 155(4): 1039-1045.
19. Sidhu S, Marsh DJ, Theodosopoulos G et al (2002) Comparative genomic hybridization analysis of adrenocortical tumors. J Clin Endocrinol Metab 87(7): 3467-3474.
20. Kjellman M, Kallioniemi OP, Karhu R et al (1996) Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy. Cancer Res 56(18): 4219-4223.
21. Dohna M, Reincke M, Mincheva A, Allolio B, Solinas-Toldo S, Lichter P (2000) Adrenocortical carcinoma is characterized by a high frequency of chromosomal gains and high-level amplifications. Genes Chromosomes Cancer 28(2): 145-152.
22. Bernard MH, Sidhu S, Berger N et al (2003) A case report in favor of a multistep adrenocortical tumorigenesis. J Clin Endocrinol Metab 88(3): 998-1001.
23. Kjellman M, Larsson C, Backdahl M (2001) Genetic background of adrenocortical tumor development. World J Surg 25(7): 948-956.